Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: comment on the article by Wessels et al.
Warren
R B
RB
Gibbons
L J
LJ
D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D030561:Databases, Nucleic Acid; D012696:Glycine Hydroxymethyltransferase / Q000235:genetics*; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP) / Q000235:genetics*; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*
D018501:Antirheumatic Agents; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP); D012696:Glycine Hydroxymethyltransferase; C520541:SHMT protein, human; D008727:Methotrexate